GE Vernova GEV Q1 2026 Earnings Beat Revenue NA EPS 208 Accuray ARAY Slides 520 as Selling Pressure Mounts 20260515 Brill Earth BRLT Reports Mixed Q1 2026 Revenue Beats but EPS Misses Trump Urges Restraint Between China and Taiwan Trade Talks in Focus Nvidia Stock Approaches Critical Technical Level Traders Eye Potential Breakout Chinas Chip Exports Surge to 31 Billion Amid US Restrictions and AI Boom April Jobs Report Preview Labor Market Cooling Yet Resilient Amid Economic Challenges European Space Sector Monitors SpaceX IPO Preparations Mastercard Obtains New York BitLicense Expanding Digital Asset Capabilities Malaysian Food Startup Targets Commercialization of LabGrown Unagi Westwater Resources Inc WWR Q1 2026 Earnings Modest EPS Beat as PreRevenue Graphite Developer Advances RRX Q1 2026 Earnings Earnings Beat on Solid Execution Amid Mixed Market Conditions KYIV Q1 2026 Earnings EPS Surpasses Estimates Amid Challenging Macro Environment AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress BKV Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed DIBS Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment PIMCO Access Income Fund PAXS Shows Resilience with 107 Gain Tests Key Resistance Humana HUM Holds Steady Near Support A Cautious Recovery in Managed Care INNEOVA Holdings Limited INEO Holds Near Support Amid Slight Pullback Republic Digital Acquisition Warrants RDAGW Hold Steady at 043 as Trading Remains RangeBound ZenaTech ZENA Sees 382 Decline Tests Near Key Support at 132 Pony AI Shares Touch 52Week Low Amid 40 YTD Decline Oversold Conditions Eyed Nansledan Development in Cornwall CommunityFocused Retail Model May Reshape Local High Street Dynamics Salesforce Shares Dip Following Soft Revenue Forecast Amid AI Transformation Pressures NRx Pharmaceuticals NRXP Gains Attention as Wall Street AnalystRated Penny Stock Americans Views on Trump Trade and Tariff Policies Draw Mixed Sentiment Pew Survey Indicates XRP Ledgers May 27 Upgrade Draws Attention for Its Broader Potential GNL Q1 2026 Earnings Massive EPS Miss of 179 Sends Shares Lower Rein Therapeutics RNTX Slips Near Support Key Levels Tested